Suppr超能文献

急性心肌梗死致心源性休克患者冠状动脉再灌注前体外膜肺氧合(ECMO)支持的结果

Results of Extracorporeal Membrane Oxygenation (ECMO) Support before Coronary Reperfusion in Cardiogenic Shock with Acute Myocardial Infarction.

作者信息

Chung Eui Suk, Lim Cheong, Lee Hae-Young, Choi Jin-Ho, Lee Jeong-Sang, Park Kay-Hyun

机构信息

Department of Thoracic and Cardiovascular Surgery, Sanggye Paik Hospital, Inje University, Korea.

出版信息

Korean J Thorac Cardiovasc Surg. 2011 Aug;44(4):273-8. doi: 10.5090/kjtcs.2011.44.4.273. Epub 2011 Aug 18.

Abstract

BACKGROUND

Despite aggressive treatment, the mortality rate of cardiogenic shock with acute myocardial infarction (AMI) is high. We performed extracorporeal membrane oxygenation (ECMO) prior to coronary reperfusion, and evaluated the early clinical results and risk factors.

MATERIALS AND METHODS

From May 2006 to November 2009, we reviewed the medical records of 20 patients in cardiogenic shock with AMI (mean age 67.7±11.7 yrs, M : F 14 : 6). After initially performing ECMO using the CAPIOX emergency bypass system (EBS®Terumo, Tokyo, Japan), patients underwent coronary reperfusion (coronary artery bypass grafting, 13; percutaneous coronary intervention, 7).

RESULTS

All patients were in a cardiogenic shock state, cardiopulmonary resuscitations (CPR) were performed for fourteen patients (mean CPR time 20.8±26.0 min). The mean time from vascular access to the initiation of ECMO was 17.2±9.4 min and mean support time was 3.8±4.0 days. Fourteen patients were able to be weaned from ECMO and ten patients were discharged (mean admission duration 50.1±31.6 days). Patients survived on average 476.6±374.6 days of follow-up. Longer CPR and support time, increased cardiac enzyme, lower ejection fraction, lower albumin, and major complications were the risk factors of mortality (p<0.05).

CONCLUSION

The early application of ECMO prior to coronary reperfusion and control of risk factors allowed for good clinical results in cardiogenic shock with AMI.

摘要

背景

尽管进行了积极治疗,急性心肌梗死(AMI)所致心源性休克的死亡率仍很高。我们在冠状动脉再灌注之前实施了体外膜肺氧合(ECMO),并评估了早期临床结果和危险因素。

材料与方法

2006年5月至2009年11月,我们回顾了20例AMI所致心源性休克患者的病历(平均年龄67.7±11.7岁,男∶女为14∶6)。最初使用CAPIOX紧急旁路系统(EBS®Terumo,日本东京)进行ECMO后,患者接受了冠状动脉再灌注(冠状动脉旁路移植术13例;经皮冠状动脉介入治疗7例)。

结果

所有患者均处于心源性休克状态,14例患者进行了心肺复苏(CPR)(平均CPR时间20.8±26.0分钟)。从血管通路建立到开始ECMO的平均时间为17.2±9.4分钟,平均支持时间为3.8±4.0天。14例患者能够脱离ECMO,10例患者出院(平均住院时间50.1±31.6天)。患者平均随访存活476.6±374.6天。较长的CPR时间和支持时间、心肌酶升高、射血分数降低、白蛋白降低以及主要并发症是死亡的危险因素(p<0.05)。

结论

冠状动脉再灌注前早期应用ECMO并控制危险因素可使AMI所致心源性休克取得良好的临床效果。

相似文献

引用本文的文献

8
Rescue extracorporeal membrane oxygenation for refractory cardiogenic shock.用于难治性心源性休克的挽救性体外膜肺氧合
Postepy Kardiol Interwencyjnej. 2015;11(4):327-9. doi: 10.5114/pwki.2015.55605. Epub 2015 Jan 12.

本文引用的文献

2
Percutaneous left ventricular support devices.经皮左心室辅助装置。
Cardiol Clin. 2010 Feb;28(1):169-84. doi: 10.1016/j.ccl.2009.09.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验